fake-money-counter-counterfeit
28 March 2013Big Pharma

Confidence in the face of counterfeits

When you think of counterfeit goods, what comes to mind? Many would say fake purses, fake watches and other similar products you might find being hawked on street corners. What about counterfeit drugs? Would counterfeiters dare to enter such a highly regulated industry? Or attempt to replicate a product that is potentially life-changing and even life-saving, and so difficult to manufacture and distribute safely and correctly? Sadly, yes—drugs are among the many types of products targeted by counterfeiters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
10 March 2026   UK government funding will support the London-based IP crime unit until 2029, as EUIPO and European authorities step up efforts to tackle unsafe counterfeits.
Big Pharma
11 February 2026   Courts on both sides of the Atlantic recorded a flurry of settlements this week, as Astellas, GSK, and Alexion drew a line under long-running disputes with generic rivals.
Big Pharma
27 November 2025   Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.